Pediatric Patients Demonstrate Progressive T1-Weighted Hyperintensity in the Dentate Nucleus following Multiple Doses of Gadolinium-Based Contrast Agent.
about
Safety assessment of gadolinium-based contrast agents (GBCAs) requires consideration of long-term adverse effects in all human tissuesDeep Brain Nuclei T1 Shortening after Gadobenate Dimeglumine in Children: Influence of Radiation and Chemotherapy.Gadolinium Retention, Brain T1 Hyperintensity, and Endogenous Metals: A Comparative Study of Macrocyclic Versus Linear Gadolinium Chelates in Renally Sensitized Rats.The Effects of Gadolinium-Based Contrast Agents on the Cerebellum: from Basic Research to Neurological Practice and from Pregnancy to Adulthood.Editor's Highlight: In Utero Exposure to Gadolinium and Adverse Neonatal Outcomes in Premature Infants.Reply to Radbruch et al.: 'interpreting signal-intensity ratios without visible T1 hyperintensities in clinical gadolinium retention studies'.A Pharmacokinetics, Efficacy, and Safety Study of Gadoterate Meglumine in Pediatric Subjects Aged Younger Than 2 Years.Development of High Signal Intensity within the Globus Pallidus and Dentate Nucleus following Multiple Administrations of Gadobenate Dimeglumine.Interpreting signal-intensity ratios without visible T1 hyperintensities in clinical gadolinium retention studies.Magnetic resonance imaging to diagnose leptomeningeal spread of medulloblastoma in children: Decreasing diagnostic uncertainty, moving in new directions.Intestinal ultrasound and management of small bowel Crohn's disease.Gadolinium Deposition in Brain: Current Scientific Evidence and Future Perspectives
P2860
Q33613096-74EAFDB1-01A1-45CB-9CCD-2C9FF5D1C78AQ47340326-24E70BC4-F9E6-4AD8-8B83-2F3DE1867289Q47867533-53E8C81A-8C4A-404F-A03A-D743D79F4697Q47939060-FA0E5A42-8BDD-4326-9259-185EC7E69BB1Q47974051-B704E1BA-BB24-4773-A5E6-21322A2A321AQ48107141-98BE6C76-E551-4093-9609-A7F22E7DD387Q48113624-B6B4C5B5-CE23-4045-8366-708C5DE23B4AQ48216879-2202D16A-6710-4774-B06C-E522FE89DD3EQ50072903-483EF36C-6A8C-4E91-9420-0676ED892A3EQ53408456-47C6F1A9-BA35-459E-A7E7-7C26C1751BA4Q55091445-E653F997-C20D-4D2E-AFB8-F7E7C1F4AE02Q57191777-0CFD71CE-1FE5-4DE5-A1AD-94F41BDA2D9C
P2860
Pediatric Patients Demonstrate Progressive T1-Weighted Hyperintensity in the Dentate Nucleus following Multiple Doses of Gadolinium-Based Contrast Agent.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 28 July 2016
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Pediatric Patients Demonstrate ...... dolinium-Based Contrast Agent.
@en
Pediatric Patients Demonstrate ...... dolinium-Based Contrast Agent.
@nl
type
label
Pediatric Patients Demonstrate ...... dolinium-Based Contrast Agent.
@en
Pediatric Patients Demonstrate ...... dolinium-Based Contrast Agent.
@nl
prefLabel
Pediatric Patients Demonstrate ...... dolinium-Based Contrast Agent.
@en
Pediatric Patients Demonstrate ...... dolinium-Based Contrast Agent.
@nl
P2093
P2860
P50
P356
P1476
Pediatric Patients Demonstrate ...... adolinium-Based Contrast Agent
@en
P2093
A R Chatterjee
D R Roberts
J M Jenrette
P J Nietert
P2860
P304
P356
10.3174/AJNR.A4891
P50
P577
2016-07-28T00:00:00Z